Home » Stocks » Bristol Myers Squibb

Bristol Myers Squibb (BMY) Stock Price & AI Analysis

$46.45

-$0.43

(0.92%)

Pharmaceuticals

NYSE

May 12, 9:18 PM EDT

Market Cap.
94.53B
Volume
14.91M
Avg. Volume
14.02M
Target Price
$56.05
52W Range
39.35 - 63.33

RSI (14)
30.31
Beta
0.4
PEG Ratio
0.24
SMA 20
-5.32%
SMA 50
-15.56%
SMA 200
-14.31%

Insider Owner
0.08%
Insider Trans
0.5%
Institution Owner
82.37%
Institution Trans
2.06%
Short Interest
30.03%
EPS next Y
-11.54

Bristol Myers Squibb Company Profile

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Analyst recommendations

Bristol Myers Squibb | Latest news

BMY Q1 Earnings Call: Growth Portfolio Offsets Declines, Guidance Raised Amid...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results exceeding the...

StockStory - 15 hours ago

Stock Market Today: Stocks soar as the U.S. and China agree tariff pause

Eli Lilly (LLY) shares were marked 2.66% lower in premarket trading, with Pfizer (PFE) down 3.01%...

TheStreet - 12 hours ago

... 'Profound' Than Autonomous Taxi Networks, Humanoid Robots - Amgen...

The Founder, CEO, and CIO of Ark Invest, Cathie Wood, has highlighted the rising applications of...

Benzinga - 14 hours ago

Bristol-Myers Squibb (NYSE:BMY) Appoints Cari Gallman As New General Counsel

Bristol-Myers Squibb (NYSE:BMY) recently appointed Cari Gallman as the new Executive Vice President,...

Simply Wall St - 6 days ago

Bristol-Myers Squibb Company (BMY): One of the Best High-Yield Dividend Stocks...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this...

Insider Monkey - 3 days ago

Bristol-Myers Squibb Co (BMY) Shares Decline Despite Market Challenges – News...

Bristol-Myers Squibb Co (NYSE: BMY) has seen a decline in its stock price by -4.97 in relation to its previous close of 50.06. Is It Worth Investing in Bristol-Myers Squibb Co (NYSE: BMY) Right ...

NewsHeater - 6 days ago

Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock

Bristol Myers Squibb (BMY) New York-based Bristol-Myers Squibb is one of the leading global...

Zacks - 4 days ago

EXCLUSIVE: FDA Clears Lantern Pharma's Planned Phase 1b/2 Trial of LP-184 In...

Investigational New Drug (IND) application for the Phase 1b/2 trial of LP-184 in a genomically...

Benzinga - 13 hours ago

Q2 EPS Estimate for Bristol-Myers Squibb Boosted by Analyst

Bristol-Myers Squibb (NYSE:BMY – Free Report) – Stock analysts at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for shares of Bristol-Myers Squibb in a research report ...

ETF DAILY NEWS - 2 days ago

Health Care Stocks (IBB) Live: President Trump Promises Lower Drug Prices,...

Live Updates Live Coverage Has Ended Pharmaceutical Stocks are Still Erasing Earlier Losses 11:44 am...

247wallstcom - 10 hours ago